Lek Pharmaceuticals d.d. PharOS Mt Ltd
PolandAll drugs from this manufacturer
-
The medicine is intended for adult men with prostate cancer for whom hormonal or surgical treatment is no longer effective, or in cases where the cancer has spread to other parts of the body.
Dosage form: tablets, film-coated
Active substance Dosage enzalutamide 40 mg ATC: L02BB04
-
This medicine is used in adult men to treat prostate cancer that does not respond to hormonal therapy or surgical treatment, or that has spread to other parts of the body. It is also used in men after prostate removal or radiation therapy, in whom there has been a rapid increase in PSA levels.
Dosage form: tablets, film-coated
Active substance Dosage enzalutamide 80 mg ATC: L02BB04
-
The medicine is used in adults who had a heart attack more than a year ago. It helps to reduce the risk of another heart attack, stroke, or death from cardiovascular causes.
Dosage form: tablets, film-coated
Active substance Dosage ticagrelor 60 mg ATC: B01AC24
-
The medicine is used in adults who have experienced a heart attack or unstable angina pectoris. It helps to reduce the risk of another heart attack, stroke, or death from cardiovascular causes.
Dosage form: tablets, film-coated
Active substance Dosage ticagrelor 90 mg ATC: B01AC24